Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891360169> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2891360169 endingPage "9076" @default.
- W2891360169 startingPage "9076" @default.
- W2891360169 abstract "9076 Background: PD-1/PD-L1 axis inhibitors have been proven effective, especially in patients expressing Programmed Death Ligand 1 (PD-L1). Their clinical efficacy in patients with epidermal growth factor receptor (EGFR) activating mutations is still unclear, while KRAS mutations seem to be associated with high response rates. In this study we investigated the expression of PD-L1, PD-L2 and Tumor Infiltrating Lymphocyte (TIL) status as a function of mutation status in Non-Small Cell Lung Cancer (NSCLC). Methods: We used the AQUA method of quantitative fluorescence (QIF) to compare PD-L1 and PD-L2 expression and to characterize TILs populations and their activation status in over 150 NSCLC patient tumors with known mutation status. EGFR activation was assessed in situ using the proximity ligation assay (PLA) for EGFR and GRB2 and T cell activation was assessed using a novel multiplexed QIF assay including CD3, Granzyme B and Ki67. Results: PD-L1 tumor and stroma expression was significantly lower in EGFR mutant compared to KRAS mutant (p = 0.009) and EGFR/KRAS Wild Type (p < 0.0001) tumors, while they had a higher frequency of PD-L2 expression. Conversely, KRAS mutants had significantly lower PD-L2 tumor and stroma expression but they were also more inflamed with higher CD4+, CD8+ and CD20+ TILs. Subgroup analysis of patients by their TILs activation status revealed that EGFR mutants had a very high frequency of inactive TILs even though lymphocytes were present in the tumor microenvironment. In contrast, in KRAS mutants, when TILs were present, they were almost always active. Finally, we find that PLA-defined activated EGFR correlated with increased PD-L1 expression in EGFR mutants but not in EGFR WT, while TIL activation was associated with higher PD-L1 in EGFR/KRAS WT. Conclusions: Our findings are consistent with the unique biology of EGFR mutant tumors. The high frequency of inactive TILs could explain the low immune therapy response rates in this patient group. Similarly, in this group, the reason PD-L1 expression fails to predict response may be due to expression as a result of constitutive oncogenic signaling rather than immune signaling, which would be associated with high PD-L1 levels and TILs activation." @default.
- W2891360169 created "2018-09-27" @default.
- W2891360169 creator A5002620104 @default.
- W2891360169 creator A5015800207 @default.
- W2891360169 creator A5019551393 @default.
- W2891360169 creator A5027326018 @default.
- W2891360169 creator A5027790861 @default.
- W2891360169 creator A5029434966 @default.
- W2891360169 creator A5039160380 @default.
- W2891360169 creator A5058805895 @default.
- W2891360169 creator A5069499235 @default.
- W2891360169 date "2017-05-20" @default.
- W2891360169 modified "2023-10-17" @default.
- W2891360169 title "Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations." @default.
- W2891360169 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.9076" @default.
- W2891360169 hasPublicationYear "2017" @default.
- W2891360169 type Work @default.
- W2891360169 sameAs 2891360169 @default.
- W2891360169 citedByCount "3" @default.
- W2891360169 countsByYear W28913601692017 @default.
- W2891360169 countsByYear W28913601692018 @default.
- W2891360169 countsByYear W28913601692022 @default.
- W2891360169 crossrefType "journal-article" @default.
- W2891360169 hasAuthorship W2891360169A5002620104 @default.
- W2891360169 hasAuthorship W2891360169A5015800207 @default.
- W2891360169 hasAuthorship W2891360169A5019551393 @default.
- W2891360169 hasAuthorship W2891360169A5027326018 @default.
- W2891360169 hasAuthorship W2891360169A5027790861 @default.
- W2891360169 hasAuthorship W2891360169A5029434966 @default.
- W2891360169 hasAuthorship W2891360169A5039160380 @default.
- W2891360169 hasAuthorship W2891360169A5058805895 @default.
- W2891360169 hasAuthorship W2891360169A5069499235 @default.
- W2891360169 hasConcept C104317684 @default.
- W2891360169 hasConcept C121608353 @default.
- W2891360169 hasConcept C126322002 @default.
- W2891360169 hasConcept C143998085 @default.
- W2891360169 hasConcept C150194340 @default.
- W2891360169 hasConcept C18431079 @default.
- W2891360169 hasConcept C203014093 @default.
- W2891360169 hasConcept C2776256026 @default.
- W2891360169 hasConcept C2777701055 @default.
- W2891360169 hasConcept C2781053074 @default.
- W2891360169 hasConcept C502942594 @default.
- W2891360169 hasConcept C54355233 @default.
- W2891360169 hasConcept C71924100 @default.
- W2891360169 hasConcept C86803240 @default.
- W2891360169 hasConcept C8891405 @default.
- W2891360169 hasConceptScore W2891360169C104317684 @default.
- W2891360169 hasConceptScore W2891360169C121608353 @default.
- W2891360169 hasConceptScore W2891360169C126322002 @default.
- W2891360169 hasConceptScore W2891360169C143998085 @default.
- W2891360169 hasConceptScore W2891360169C150194340 @default.
- W2891360169 hasConceptScore W2891360169C18431079 @default.
- W2891360169 hasConceptScore W2891360169C203014093 @default.
- W2891360169 hasConceptScore W2891360169C2776256026 @default.
- W2891360169 hasConceptScore W2891360169C2777701055 @default.
- W2891360169 hasConceptScore W2891360169C2781053074 @default.
- W2891360169 hasConceptScore W2891360169C502942594 @default.
- W2891360169 hasConceptScore W2891360169C54355233 @default.
- W2891360169 hasConceptScore W2891360169C71924100 @default.
- W2891360169 hasConceptScore W2891360169C86803240 @default.
- W2891360169 hasConceptScore W2891360169C8891405 @default.
- W2891360169 hasIssue "15_suppl" @default.
- W2891360169 hasLocation W28913601691 @default.
- W2891360169 hasOpenAccess W2891360169 @default.
- W2891360169 hasPrimaryLocation W28913601691 @default.
- W2891360169 hasRelatedWork W2608102145 @default.
- W2891360169 hasRelatedWork W2804050059 @default.
- W2891360169 hasRelatedWork W2894023816 @default.
- W2891360169 hasRelatedWork W2898400591 @default.
- W2891360169 hasRelatedWork W2981411598 @default.
- W2891360169 hasRelatedWork W2989589712 @default.
- W2891360169 hasRelatedWork W3031158066 @default.
- W2891360169 hasRelatedWork W3037566153 @default.
- W2891360169 hasRelatedWork W3157248895 @default.
- W2891360169 hasRelatedWork W3157820446 @default.
- W2891360169 hasVolume "35" @default.
- W2891360169 isParatext "false" @default.
- W2891360169 isRetracted "false" @default.
- W2891360169 magId "2891360169" @default.
- W2891360169 workType "article" @default.